GOLDSMITH MARK A bought RVMD
November 7, 2025 · Form 4 insider transaction
GOLDSMITH MARK A bought 3,521 shares of Revolution Medicines, Inc. at $4.09 per share, a transaction worth $14.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,521
Price
$4.09
Total value
$14.4K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after377,863
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust.; Includes 193,475 restricted stock units.